Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Chien-Hui Ou"'
Autor:
Che-Yuan Hu, Bing-Hua Su, Ya-Che Lee, Chung-Teng Wang, Mei-Lin Yang, Wan-Ting Shen, Jing-Ting Fu, Shih-Yao Chen, Wei-Yun Huang, Chien-Hui Ou, Yuh-Shyan Tsai, Feng-Chih Kuo, Ai-Li Shiau, Gia-Shing Shieh, Chao-Liang Wu
Publikováno v:
Journal of Biomedical Science. 29
Background Cisplatin-based chemotherapy is the first line of treatment for bladder cancer. However, cisplatin induces muscle wasting associated with NF-κB and cancer cachexia. HOTAIR, an oncogenic long non-coding RNA (lncRNA), promotes cancer progre
Publikováno v:
International Urology and Nephrology. 54:63-69
The prognosis of patients undergoing 2-sided radical nephroureterectomies (RNUs) with a residual bladder due to bilateral upper tract urothelial carcinoma (UTUC) is poorly understood. This study was aimed toward surveying the oncology outcomes and pr
Autor:
Yuh-Shyan, Tsai, Tzu-Yi, Wu, Chien-Hui, Ou, Hong-Lin, Cheng, Tzong-Shin, Tzai, Wen-Horng, Yang, Jung-Der, Wang
Publikováno v:
BMC Urology. 22
Background To explore the dynamic changes and effects of radical cystectomy on quality of life in muscle-invasive bladder cancer survivors. Methods Patients with muscle-invasive bladder cancer were randomly recruited in this study. We used the World
Autor:
Yun Chen Huang, Pei Chi Hou, Che Yuan Hu, Hsiu Chi Lee, Chien-Hui Ou, Shih Chieh Lin, Yi Syuan Lin, Chad J. Creighton
Publikováno v:
Oncogene
Metastatic castration-resistant prostate cancer (mCRPC) is a malignant and lethal disease caused by relapse after androgen-deprivation (ADT) therapy. Since enzalutamide is innovated and approved by US FDA as a new treatment option for mCRPC patients,
Autor:
Han Yu Weng, Chien-Hui Ou
Publikováno v:
International Urology and Nephrology. 52:2275-2279
To maximize the chance of maintaining peritoneal dialysis (PD) after retroperitoneoscopic nephroureterectomy without interruption in PD-dependent patients who were suspected as having upper tract urothelial carcinoma (UTUC). During 2005–2018 at our
Publikováno v:
Annals of Surgical Oncology. 26:669-684
This study aimed to evaluate the clinical significance of the preoperative systemic immune-inflammation index (SII) combined with the monocyte-lymphocyte ratio (MLR) for patients with upper-tract urothelial carcinoma (UTUC). The clinical data of 424
Autor:
Yung Tai Chen, Chi Wen Lo, Che Wei Chang, Hsiang Ying Lee, Pai Yu Cheng, Ching Chia Li, Chia Chang Wu, Chung You Tsai, Hsu Che Huang, Chih Chin Yu, Chien Hui Ou
Publikováno v:
BMC Cancer
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Background A high incidence of upper urinary tract urothelial carcinoma has been reported in the southwestern area of Taiwan, where arsenic water contamination was considered the main cause. However, there is no definite proof to show a correlation b
Autor:
Che Yuan Hu, Chad J. Creighton, Hsiu Chi Lee, Pei Chi Hou, Yi Syuan Lin, Chien-Hui Ou, Shih Chieh Lin, Yun Chen Huang
Publikováno v:
Oncogene. 40:4060-4060
Autor:
Chien-Hui Ou, Wen-Horng Yang
Publikováno v:
International Urology and Nephrology. 49:623-627
To survey long-term outcomes of dialysis patients with urothelial cancers who have undergone complete urinary tract exenteration (bilateral nephroureterectomy and cystectomy). We retrospectively reviewed our patients with urinary tract urothelial can